Stay updated with breaking news from Hematologic Malignancies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A liquid biopsy test used for molecular profiling in patients with solid tumors also identified patients who were at risk for clonal hematopoiesis, which may develop into myeloid blood cancer.
Company announces SCINTIX as new product name for its flagship biology-guided radiotherapy technology
Patients with diverticular disease have a 33% increased overall cancer risk compared with the general population, equivalent to one extra case in 16 patients with diverticulosis followed for 10 years.
Although the findings focus on deaths before vaccines became available, the data can help researchers better understand some of the burden COVID-19 had on patients with cancer.
/PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today...